What genetic disorder indicates sapropterin use?

What genetic disorder is treated with sapropterin (BH4)?

Sapropterin (a synthetic form of tetrahydrobiopterin, BH4) is used to treat disorders caused by defects in the BH4 pathway, most notably phenylketonuria (PKU), including BH4-responsive (responsive) hyperphenylalaninemia. In these conditions, sapropterin helps lower elevated blood phenylalanine levels by supporting phenylalanine metabolism [1].

Is it only for PKU, or are there other conditions?

Sapropterin is also used in BH4-responsive hyperphenylalaninemia (a broader label that includes some PKU variants) [1]. It is tied to whether the underlying condition is expected to respond to BH4 support.

How do clinicians decide if sapropterin will work?

Whether sapropterin is indicated depends on the person’s type of hyperphenylalaninemia/PKU and whether their condition is BH4-responsive, which is determined through clinical evaluation and testing strategies used in practice for PKU responsiveness [1].

What does “sapropterin use indicates” in test or chart language?

If a record notes that a patient is on sapropterin, it commonly signals they have BH4-responsive hyperphenylalaninemia/PKU, because sapropterin’s main clinical use is lowering phenylalanine in BH4-responsive cases [1].

Sources

1. https://www.ncbi.nlm.nih.gov/books/NBK525993/